A bone-crushing side effect? The benefits of GLP-1 drugs like Ozempic are myriad, from weight loss to improved cardiovascular health to potentially preventing dementia, lowering the risk of depression, and reducing the intensity of migraines. However, new research suggests these wildly popular meds could substantially raise your risk of developing a different serious condition. The research team … Read more
Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, from improving cardiovascular health to potentially preventing dementia and lowering the risk of depression. Now, one more benefit could be added to the list, thanks to new research that found the blockbuster drugs could be a … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar with prediabetes? Prediabetes is a state of elevated blood sugar that falls below the threshold of Type 2 diabetes. It’s becoming increasingly common: More than 1 in 3 US adults has prediabetes, and most aren’t … Read more
A high profile celebrity chef in Los Angeles is changing up the menu in his string of critically acclaimed restaurants to better serve clients who are dropping pounds at a record pace thanks to the help of weight loss shots. Chef Andrew Gruel says he’s cutting way back on foods loaded with carbs — like … Read more
The pandemic changed how Americans think about health — and who they trust to manage it. In the wreckage of lockdowns, millions turned away from doctors and toward influencers. Now, a growing number of wellness creators and everyday people are taking their health — and appearance — into their own hands. Literally. Across TikTok, Telegram … Read more
That’s some serious star power! Shortly after his baffling Pizza Hut commercial dropped, ex-NFL star Tom Brady was named chief wellness officer of eMed, a digital health platform for GLP-1 drugs and more. The seven-time Super Bowl champion, 48, joins the ranks of superstar athletes promoting the blockbuster weight loss and diabetes meds, a head-scratching … Read more
Too good to be true? While blockbuster GLP-1 drugs continue to reach new heights in popularity, they’re not without potential downsides, like bizarre side effects such as “Ozempic feet.” And while they boast impressive blood sugar and weight loss results — average weight lost is nearly 10% over a year — making one mistake could … Read more
New York City has one of the highest ratios of plastic surgeons per capita — but New Yorkers are still flying across the country for a buzzy new antiaging treatment. Lauren Goodman, a registered nurse and founder of Juliana Clinics in Beverly Hills, says she’s had people traveling from around the US to be “shrink … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly … Read more
Derek Bartel didn’t recognize himself. Looking back at photos from a recent trip, he was convinced his wife had pulled a prank. “Oh my god, is that me?” Bartel, 39, recalled thinking, certain she’d edited the images to make him look wider. “There’s no way I look like that.” But it was him — every shocking, … Read more
Kathy Bates is continuing to show off the remarkable results of her weight loss journey. The “Matlock” star, 77, proudly revealed her slimmed-down figure at the 2026 Critics Choice Awards in Santa Monica, Calif. on Sunday night. Bates, who lost 100 pounds in part thanks to taking Ozempic, wore a black blazer and matching tailored … Read more
About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so dramatically that people are spending noticeably less on groceries. But one dietitian and LillyDirect partner — a platform from Eli Lilly, which sells Mounjaro and Zepbound — tells The Post there are actually lots of … Read more
You’ve heard of the rise of “Ozempic babies” — where women who’ve previously struggled with infertility get knocked up on GLP-1s — but new research shows that going off those drugs may have a negative impact on pregnancy. A new study from Mass General Brigham found that women who stopped taking popular GLP-1 medications before … Read more
On average, Americans want to live to be 91 years old, according to a recent Pew Research survey — a goal that has driven a focus on longevity-boosting practices. Over 60% of U.S. adults use supplements and most prioritize long-term health and wellness behaviors as part of an anti-aging approach, research has shown. In 2025, researchers revealed … Read more
The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment cleared for use without injections. “As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy … Read more
Here’s the skinny on Chipotle’s new “GLP-1 friendly” menu. This coming Tuesday, Chipotle will debut its High Protein Menu –and it proves how weight-loss drugs such as Ozempic and Wegovy are altering the way people eat. “With the rise of GLP-1s and a broader focus on macronutrients, Chipotle’s new High Protein Menu offers more ways … Read more
Meowzempic is here. Experts estimate that more than half of the world’s pet cats are overweight — and now the flabby tabbies might soon have their own version of Ozempic. Pet meds company OKAVA Pharmaceuticals has announced that the first clinical trial — dubbed MEOW-1 (ManagEment of OverWeight cats with OKV-119) — for a feline … Read more
There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: patients sliding back into restrictive eating disorders — and others developing them for the first time. “I think there should be a button that you have to … Read more
Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by suppressing appetite, this new treatment boosts metabolism in the muscles. A study led by researchers at Karolinska Institutet and Stockholm University included both … Read more